Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus

Abstract Streptococcus gallolyticus is a non-motile, gram-positive bacterium that causes infective endocarditis. S. gallolyticus has developed resistance to existing antibiotics, and no vaccine is currently available. Therefore, it is essential to develop an effective S. gallolyticus vaccine. Core p...

Full description

Bibliographic Details
Main Authors: Peng Chao, Xueqin Zhang, Lei Zhang, Aiping Yang, Yong Wang, Xiaoyang Chen
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-55372-3
_version_ 1797274552488689664
author Peng Chao
Xueqin Zhang
Lei Zhang
Aiping Yang
Yong Wang
Xiaoyang Chen
author_facet Peng Chao
Xueqin Zhang
Lei Zhang
Aiping Yang
Yong Wang
Xiaoyang Chen
author_sort Peng Chao
collection DOAJ
description Abstract Streptococcus gallolyticus is a non-motile, gram-positive bacterium that causes infective endocarditis. S. gallolyticus has developed resistance to existing antibiotics, and no vaccine is currently available. Therefore, it is essential to develop an effective S. gallolyticus vaccine. Core proteomics was used in this study together with subtractive proteomics and reverse vaccinology approach to find antigenic proteins that could be utilized for the design of the S. gallolyticus multi-epitope vaccine. The pipeline identified two antigenic proteins as potential vaccine targets: penicillin-binding protein and the ATP synthase subunit. T and B cell epitopes from the specific proteins were forecasted employing several immunoinformatics and bioinformatics resources. A vaccine (360 amino acids) was created using a combination of seven cytotoxic T cell lymphocyte (CTL), three helper T cell lymphocyte (HTL), and five linear B cell lymphocyte (LBL) epitopes. To increase immune responses, the vaccine was paired with a cholera enterotoxin subunit B (CTB) adjuvant. The developed vaccine was highly antigenic, non-allergenic, and stable for human use. The vaccine's binding affinity and molecular interactions with the human immunological receptor TLR4 were studied using molecular mechanics/generalized Born surface area (MMGBSA), molecular docking, and molecular dynamic (MD) simulation analyses. Escherichia coli (strain K12) plasmid vector pET-28a ( +) was used to examine the ability of the vaccine to be expressed. According to the outcomes of these computer experiments, the vaccine is quite promising in terms of developing a protective immunity against diseases. However, in vitro and animal research are required to validate our findings.
first_indexed 2024-03-07T15:00:01Z
format Article
id doaj.art-057b73d582f546029a1a1945c0238a44
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-07T15:00:01Z
publishDate 2024-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-057b73d582f546029a1a1945c0238a442024-03-05T19:11:02ZengNature PortfolioScientific Reports2045-23222024-02-0114111510.1038/s41598-024-55372-3Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticusPeng Chao0Xueqin Zhang1Lei Zhang2Aiping Yang3Yong Wang4Xiaoyang Chen5Department of Cardiology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Nephrology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Cardiology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Traditional Chinese Medicine, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Cardiology, People’s Hospital of Xinjiang Uygur Autonomous RegionDepartment of Cardiology, People’s Hospital of Xinjiang Uygur Autonomous RegionAbstract Streptococcus gallolyticus is a non-motile, gram-positive bacterium that causes infective endocarditis. S. gallolyticus has developed resistance to existing antibiotics, and no vaccine is currently available. Therefore, it is essential to develop an effective S. gallolyticus vaccine. Core proteomics was used in this study together with subtractive proteomics and reverse vaccinology approach to find antigenic proteins that could be utilized for the design of the S. gallolyticus multi-epitope vaccine. The pipeline identified two antigenic proteins as potential vaccine targets: penicillin-binding protein and the ATP synthase subunit. T and B cell epitopes from the specific proteins were forecasted employing several immunoinformatics and bioinformatics resources. A vaccine (360 amino acids) was created using a combination of seven cytotoxic T cell lymphocyte (CTL), three helper T cell lymphocyte (HTL), and five linear B cell lymphocyte (LBL) epitopes. To increase immune responses, the vaccine was paired with a cholera enterotoxin subunit B (CTB) adjuvant. The developed vaccine was highly antigenic, non-allergenic, and stable for human use. The vaccine's binding affinity and molecular interactions with the human immunological receptor TLR4 were studied using molecular mechanics/generalized Born surface area (MMGBSA), molecular docking, and molecular dynamic (MD) simulation analyses. Escherichia coli (strain K12) plasmid vector pET-28a ( +) was used to examine the ability of the vaccine to be expressed. According to the outcomes of these computer experiments, the vaccine is quite promising in terms of developing a protective immunity against diseases. However, in vitro and animal research are required to validate our findings.https://doi.org/10.1038/s41598-024-55372-3ImmunoinformaticsReverse vaccinologyPan-genomeMulti-epitope vaccine
spellingShingle Peng Chao
Xueqin Zhang
Lei Zhang
Aiping Yang
Yong Wang
Xiaoyang Chen
Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus
Scientific Reports
Immunoinformatics
Reverse vaccinology
Pan-genome
Multi-epitope vaccine
title Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus
title_full Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus
title_fullStr Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus
title_full_unstemmed Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus
title_short Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus
title_sort proteomics based vaccine targets annotation and design of multi epitope vaccine against antibiotic resistant streptococcus gallolyticus
topic Immunoinformatics
Reverse vaccinology
Pan-genome
Multi-epitope vaccine
url https://doi.org/10.1038/s41598-024-55372-3
work_keys_str_mv AT pengchao proteomicsbasedvaccinetargetsannotationanddesignofmultiepitopevaccineagainstantibioticresistantstreptococcusgallolyticus
AT xueqinzhang proteomicsbasedvaccinetargetsannotationanddesignofmultiepitopevaccineagainstantibioticresistantstreptococcusgallolyticus
AT leizhang proteomicsbasedvaccinetargetsannotationanddesignofmultiepitopevaccineagainstantibioticresistantstreptococcusgallolyticus
AT aipingyang proteomicsbasedvaccinetargetsannotationanddesignofmultiepitopevaccineagainstantibioticresistantstreptococcusgallolyticus
AT yongwang proteomicsbasedvaccinetargetsannotationanddesignofmultiepitopevaccineagainstantibioticresistantstreptococcusgallolyticus
AT xiaoyangchen proteomicsbasedvaccinetargetsannotationanddesignofmultiepitopevaccineagainstantibioticresistantstreptococcusgallolyticus